May cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Lidocaine 5% Interactions
Brand names: Lidocaine 5%
Amide Local Anesthetic · Antiarrhythmic
Route: Topical
Contraindications
CONTRAINDICATIONS Lidocaine patch 5% is contraindicated in patients with a known history of sensitivity to local anesthetics of the amide type, or to any other component of the product.
Pregnancy & Breastfeeding
Pregnancy Teratogenic Effects Pregnancy Category B. Lidocaine patch 5% has not been studied in pregnancy. Reproduction studies with lidocaine have been performed in rats at doses up to 30 mg/kg subcutaneously and have revealed no evidence of harm to the fetus due to lidocaine. There are, however, no adequate and well-controlled studies in pregnant women. Because animal reproduction studies are not always predictive of human response, lidocaine patch 5% should be used during pregnancy only if clearly needed.
33 interactions on record
Antibiotic class that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
Antimalarial that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antineoplastic agent that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antibiotic that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antineoplastic agent that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antineoplastic agent that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antineoplastic agent that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
May cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Class I antiarrhythmic; toxic effects are additive and potentially synergistic with lidocaine patch 5%.
Source: NLP:lidocaine 5%
May cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antibiotic that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Nitrate that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Nitrite that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Nitrite that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antibiotic that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Anticonvulsant that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Anticonvulsant that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
Antimalarial that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
May cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Antineoplastic agent that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
May cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Local anesthetic; concurrent use increases risk of methemoglobinemia and requires consideration of total absorbed amount.
Source: NLP:lidocaine 5%
Class I antiarrhythmic; toxic effects are additive and potentially synergistic with lidocaine patch 5%.
Source: NLP:lidocaine 5%
Anticonvulsant that may cause methemoglobinemia when used concomitantly with lidocaine patch 5%.
Source: NLP:lidocaine 5%
When used concomitantly with other local anesthetic products, the total amount absorbed from all formulations must be considered to avoid toxicity.
Source: NLP:lidocaine 5%